SCHEMBL5823482

SCHEMBL5823482

Fc1ccc(-c2nc(N3CCNCC3)sc2-c2n[c]ncc2C2CCCCC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.44
HTR2B P41595 4/20 0.37
HTR2A P28223 2/20 0.37
HTR2C P28335 2/20 0.37
ALDH1A1 P00352 2/20 0.35
USP2 O75604 1/20 0.35
CYP1A2 P05177 1/20 0.35
GLA P06280 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
CASP1 P29466 1/20 0.35
CYP2C19 P33261 1/20 0.35
CASP7 P55210 1/20 0.35
HIF1A Q16665 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CDK4 P11802 2/20 0.34
CCND1 P24385 2/20 0.34
HTR1A P08908 2/20 0.34
HTR7 P34969 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5823265 0.95 KCNH2 (0.44) KCNH2HTR2BALDH1A1USP2CYP1A2
SCHEMBL5818619 0.92 KCNH2 (0.39) KCNH2HTR2AHTR2CALDH1A1HTR1A
SCHEMBL5818644 0.92 KCNH2 (0.39) KCNH2HTR2AHTR2CALDH1A1HTR1A
SCHEMBL5818533 0.89 KCNH2 (0.40) KCNH2HTR2AHTR2CALDH1A1HTR1A
SCHEMBL5820465 0.89 ALDH1A2 (0.39) KCNH2HTR2BHTR2AHTR2CCDK4
SCHEMBL5818994 0.88 RCE1 (0.36) KCNH2HTR2AHTR2CALDH1A1CYP1A2
SCHEMBL5819016 0.88 KMT2A (0.46) KCNH2ALDH1A1USP2CYP1A2CYP3A4
SCHEMBL5817700 0.87 KMT2A (0.48) KCNH2HTR2BHTR2AHTR2CALDH1A1
SCHEMBL5820614 0.84 ALDH1A2 (0.41) KCNH2HTR2BHTR2AHTR2CHTR1A
SCHEMBL5819600 0.84 HTR1A (0.36) KCNH2HTR2BHTR2AHTR2CCDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed